TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,670 | -61.3% | 14,195 | +15.1% | 0.16% | -60.9% |
| Q2 2023 | $306,401 | +117746.5% | 12,335 | -28.6% | 0.41% | +7.8% |
| Q1 2023 | $260 | +23.2% | 17,276 | -3.1% | 0.38% | +58.7% |
| Q4 2022 | $211 | -99.8% | 17,826 | +3.6% | 0.24% | +126.2% |
| Q3 2022 | $102,000 | -28.7% | 17,204 | +14.6% | 0.11% | +1.9% |
| Q1 2022 | $143,000 | -50.0% | 15,018 | -0.3% | 0.10% | -45.3% |
| Q4 2021 | $286,000 | -43.4% | 15,062 | -0.7% | 0.19% | -50.6% |
| Q3 2021 | $505,000 | -13.4% | 15,175 | +1.0% | 0.39% | -14.9% |
| Q2 2021 | $583,000 | -19.3% | 15,029 | +0.3% | 0.46% | -25.2% |
| Q1 2021 | $722,000 | +862.7% | 14,984 | -15.0% | 0.61% | +426.7% |
| Q2 2020 | $75,000 | – | 17,628 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |